SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-133703
Filing Date
2020-05-05
Accepted
2020-05-05 16:06:45
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d880402d10q.htm   iXBRL 10-Q 2105409
2 EX-31.1 d880402dex311.htm EX-31.1 6396
3 EX-31.2 d880402dex312.htm EX-31.2 6418
4 EX-32.1 d880402dex321.htm EX-32.1 3862
5 EX-32.2 d880402dex322.htm EX-32.2 3849
  Complete submission text file 0001193125-20-133703.txt   6919148

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kpti-20200331.xsd EX-101.SCH 34755
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20200331_cal.xml EX-101.CAL 44329
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20200331_def.xml EX-101.DEF 180327
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20200331_lab.xml EX-101.LAB 318459
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20200331_pre.xml EX-101.PRE 264575
40 EXTRACTED XBRL INSTANCE DOCUMENT d880402d10q_htm.xml XML 1316034
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 20848843
SIC: 2834 Pharmaceutical Preparations